Transcend Capital Advisors’s GE HealthCare GEHC Stock Holding History

Transcend Capital Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249K	Sell	3,503 -172	-5%	-$13.6K	0.02%	606
2025 Q4	$301K	Sell	3,675 -179	-5%	-$13.9K	0.02%	519
2025 Q3	$289K	Buy	3,854 +887	+30%	+$66.2K	0.02%	546
2025 Q2	$220K	Sell	2,967 -744	-20%	-$51.8K	0.02%	561
2025 Q1	$299K	Buy	3,711 +542	+17%	+$46.6K	0.02%	474
2024 Q4	$248K	Sell	3,169 -142	-4%	-$12.1K	0.02%	483
2024 Q3	$311K	Sell	3,311 -72	-2%	-$6.04K	0.02%	472
2024 Q2	$264K	Sell	3,383 -6	-0.2%	-$489	0.02%	492
2024 Q1	$308K	Buy	3,389 +7	+0.2%	+$582	0.02%	405
2023 Q4	$262K	Sell	3,382 -3	-0.1%	-$210	0.02%	412
2023 Q3	$230K	Hold	3,385	–	–	0.02%	425
2023 Q2	$275K	Buy	3,385 +20	+0.6%	+$1.6K	0.03%	386
2023 Q1	$276K	Buy	+3,365	New	+$240K	0.03%	378

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Transcend Capital Advisors's GEHC Position: Q1 2026 in Review

Transcend Capital Advisors reduced its GE HealthCare (GEHC) stake by 4.7% in Q1 2026, selling an estimated $13.6K and leaving 3,503 shares worth $249K. The position accounts for 0.02% of the portfolio, ranked #606.

Transcend Capital Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $311K in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Transcend Capital Advisors held 3,503 shares of GE HealthCare worth $249K as of Q1 2026.
Transcend Capital Advisors sold 172 GE HealthCare shares in Q1 2026, an estimated $13.6K.
GE HealthCare made up 0.02% of Transcend Capital Advisors's portfolio in Q1 2026, its #606 holding.
Transcend Capital Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
Transcend Capital Advisors's GE HealthCare position peaked at $311K in Q3 2024.
1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.